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Abstract 
Purpose: To investigate the effects of Yifukang oral liquid (YFKOL) on chemotherapy- and 
radiotherapy-induced myelosuppression, leucopenia and gastrointestinal tract disturbances. 
Methods: The effects of YFKOL on myelosuppression, leucopenia and gastrointestinal tract 
disturbances were assessed by cyclophosphamide- and Co60-induced leucopenia in mice, copper 
sulfate-induced emesis in pigeons, ethanol-induced gastric mucosal lesions in rats, gastric emptying 
and intestinal propulsion in mice. 
Results: In cyclophosphamide- and Co60-induced leucopenia assays, the mean white blood cell count 
(82.6 and 90.1 × 109/L; 7.3 and 8.2 × 109/L, respectively) and thighbone marrow granulocytes (66.1 % 
and 67.4 %; 60.8 and 66.5 %, respectively) were significantly (p < 0.05) increased after treatment with 
YFKOL (15 and 30 mL/kg), compared with the respective control (68.2 and 4.7 × 109/L; 58.2 and 53.1 
%). In emesis, gastric mucosal lesions, gastric emptying and intestinal propulsion assays, the mean 
frequency of emesis (30.8 and 22.3 times, respectively) and ulcer index (39.6 and 26.5, respectively) 
significantly (p < 0.05) decreased, and the mean gastric emptying (25.0 and 24.0 %) and intestinal 
propulsion (81.9 and 82.8 %) were significantly (p < 0.05) promoted after treatment with YFKOL (10 and 
20 mL/kg), compared with the respective control (54.7 times, 62.8, 42.0 and 68.9 %). 
Conclusion: YFKOL may suppress chemotherapy- and radiotherapy-induced myelosuppression, 
leucopenia and gastrointestinal tract disturbances. 
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Currently, malignant tumor is the leading cause 
of death in human, and middle-late malignant 
tumor can cause the symptoms of anepithymia, 
muscle weakness, weight loss, hypoimmunity, 
pain, etc [1], which will become more obvious 
with the development of tumor. Chemotherapy 
and radiotherapy, the usual methods for treating 
tumor [2-5], does not only exacerbate the above 
symptoms, but also induce many toxic and side 
effects, such as myelosuppression, leucopenia, 
emesis and nausea [6-8]. 
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Based on the knowledge of traditional Chinese 
medicine, a prescription named Yifukang oral 
liquid (YFKOL) was developed by our team to 
suppress the symptoms of myelosuppression, 
leucopenia and gastrointestinal tract 
disturbances induced by chemotherapy and 
radiotherapy. YFKOL is composed of 6 kinds of 
Chinese medicines including Ginseng Radix et 
Rhizoma (200 g), Pangolin Scales (100 g), 
Angelicae Sinensis Radix (150 g), Astragali 
Complanati Semen (300 g), Scrophulariae Radix 
(200 g) and Ophiopogonis Radix (200 g).  
 
The objective of this study was to investigate the 
effects of YFKOL on chemotherapy- and 
radiotherapy-induced myelosuppression, 
leucopenia and gastrointestinal tract 
disturbances were assessed by 
cyclophosphamide- and Co60-induced 
leucopenia models in mice, copper sulfate-
induced emesis model in pigeons, ethanol-
induced gastric mucosal lesions model in rats, 
using gastric emptying and intestinal propulsion 






Ginseng Radix et Rhizoma, Pangolin Scales, 
Angelicae Sinensis Radix, Astragali Complanati 
Semen, Scrophulariae Radix and Ophiopogonis 
Radix were obtained from Beijing TongRenTang, 
Co, Ltd and the plant materials were identified by 
Shao-Jun Hao, a taxonomist, the 371st Central 
Hospital of PLA’s Pharmacy Department, 
Xinxiang Henan, China. A series of voucher 
specimen (voucher no. 201381/CPLA371, 
201382/CPLA371, 201383/CPLA371, 
201384/CPLA371, 201385/CPLA371 and 
201386/CPLA371) was stored in dispensary of 
traditional Chinese medicine of our hospital for 
future reference. 
 
Chemicals and reagents 
 
Cyclophosphamide was purchased from the 12th 
Shanghai pharmaceutical factory (batch number: 
080330). Copper sulfate was obtained from 
Zhengzhou chemical reagent first factory (batch 
number: 920429). Methyl orange was purchased 
from Shanghai reagent third factory (batch 
number: 930924). Fu Fang E Jiao Jiang (FFEJJ) 
was purchased from Shan Dong Dong-E E-Jiao 
Co., Ltd (batch number: 080112). Oulishu oral 
liquid (OLSOL) was obtained from Xinxiang 
yuanda pharmaceutical factory in China (batch 
number: 960607). 
 
Preparation of YFKOL 
 
YFKOL was provided by the 371st Central 
Hospital of PLA’s manufacturing laboratory 
(batch number: 970203). The preparation of 
YFKOL was described as follows. Ginseng Radix 
et Rhizoma (200 g), Pangolin Scales (100 g), 
Angelicae Sinensis Radix (150 g), Astragali 
Complanati Semen (300 g), Scrophulariae Radix 
(200 g) and Ophiopogonis Radix (200 g) were 
decocted with water for 40 min for three times. 
The combined decoction filtrate was 
concentrated to reach a relative density of 1.15 - 
1.30 (80 °C), then concentrate was diluted by 
ethanol to obtain 60 % ethanol solution followed 
by standing at room temperature for 24 h. After 
filtration, the obtained ethanol solution was 
condensed to remove alcohol, and simple syrup 
was added into the solution. The above solution 
was diluted by water to get 1000 mL (pH = 5.0 - 





All animal treatments in this study were in 
accordance with the National Institute of Health 
Guide for the Care and Use of Laboratory 
Animals [9] and experiments were approved by 
the ethics committee of the 371st Central 
Hospital of PLA (protocol no. PLA 371 CH 2013). 
In this research, a lot of measures were 
performed to reduce the amount of animals and 
relieve the suffering of animals. Male and female 
pigeons (300 - 450 g), SD rats (200 ± 20 g) and 
ICR mice (20 ± 2 g) were provided by Henan 
medical university laboratory animal center. 
Animals were bred with constant room 
temperature (25 ºC) and appropriate humidity (55 
– 60 %). Animals had free access to food and 
water. 
 
Acute toxicity study of YFKOL 
 
The result of acute toxicity studies of YFKOL 
showed that maximum tolerated dose (MTD) of 
YFKOL was more than 0.03 mL/g, which was far 






ICR mice were randomly divided into normal, 
control, YFKOL (high and low dose) and FFEJJ 
groups (n = 10). Control, YFKOL (high and low 
dose) and FFEJJ groups were treated with 80 
mg/kg cyclophosphamide once a day (3 days) by 
intraperitoneal injection (ip) and normal group 
was treated with isopyknic normal saline once a 
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day (3 days) by ip. Meanwhile, control, YFKOL 
(high and low dose) and FFEJJ groups were 
separately treated with normal saline, YFKOL (30 
and 15 mL/kg) and FFEJJ (30 mL/kg) once a day 
(7 days) by intragastric administration (ig) and 
normal group was treated with isopyknic normal 
saline once a day (7 days) by ig. Finally, mice 
were directly sacrificed to obtain orbital blood 
and thighbone marrow after 2 h of drugs 
treatment on the seventh day. Orbital blood was 
used to determine white blood cell count 
according to the existed method [10]. Thighbone 
marrow smears, which were stained by Wright’s 
stain, were monitored by a microscope. 
Thighbone marrow granulocytes percentage was 
used to evaluate the effect of drugs on 
cyclophosphamide-induced leucopenia [11]. 
 
Co60-induced leucopenia assay 
 
In this assay, all groups’ treatments and tests 
were the same as cyclophosphamide-induced 
leucopenia assay except that the modeling for 
control, YFKOL (high and low dose) and FFEJJ 
groups were induced by Co60. 
 
Copper sulfate-induced emesis assay 
 
Pigeons were randomly divided into control, 
YFKOL (high and low dose) and OLSOL groups 
(n = 10). Control, YFKOL (high and low doses) 
and OLSOL groups were separately treated with 
normal saline, YFKOL (20 and 10 mL/kg) and 
OLSOL (8 mL/kg) once a day (3 days) by ig. 
Then, copper sulfate was administered orally to 
pigeons of control, YFKOL (high and low dose) 
and OLSOL groups at a dose of 300 mg/kg after 
0.5 h of drugs treatment on the third day. Finally, 
the effects of drugs on copper sulfate-induced 
emesis were analyzed by incubation period and 
number of emesis within 1 h. 
 
Ethanol-induced gastric mucosal lesions 
assay 
 
SD rats were randomly divided into control, 
YFKOL (high and low dose) and OLSOL groups 
(n = 10). The treatments of all groups were the 
same as copper sulfate-induced emesis assay. 
All rats were managed with abrosia, but had free 
access to water for 12 h on the third day. 75 % 
ethanol (0.8 mL) was administered orally to each 
rat after 1.5 h of drugs treatment on the third day. 
After another one hour, mice were directly 
sacrificed for gathering stomach, which was then 
fixed by 1 % formaldehyde for 30 min. The 
situation of gastric mucosal lesions was directly 
observed. Based on gastric mucosal lesions area 
(mm2), ulcer index was calculated according to 
existing method [12]. Damage inhibition rate, 
calculated as in Eq 1, and ulcer index was used 
to evaluate the effect of drugs on 75% ethanol-
induced gastric mucosal lesions [13]. 
 
Damage inhibition rate (%) = {(A – B)/A}100 ……. (1) 
 
Where A and B stands for the ulcer index of 
control group and treatment group, respectively. 
 
Gastric emptying assay 
 
ICR mice were randomly divided into control, 
YFKOL (high and low dose) and OLSOL groups 
(n = 10). The treatments of all groups were the 
same as copper sulfate-induced emesis assay. 
All mice were managed with abrosia, but had 
free access to water for 12 h on the third day. 
Methyl orange aqueous solution (0.1 %, 0.2 mL) 
was administered orally to each mouse after 1 h 
of drugs treatment on the third day. Then, mice 
were directly sacrificed for gathering the stomach 
after 20 min of methyl orange aqueous solution 
treatment. Gastric content was washed into test 
tube by 10 mL distilled water, and the pH of 
above solution was adjusted to 6.0 - 6.5 by 5 % 
sodium bicarbonate. After filtration, the filtrate 
was analyzed by spectrophotometer at 420 nm. 
The gastric residual rate of methyl orange, used 
to evaluate the effect of drugs on gastric 
emptying, was calculated as in Eq 2 [14]. 
 
G (%) = (C/D)100 …………………….. (2) 
 
where C and D stands for the optical density 
(OD) of methyl orange in stomach and methyl 
orange aqueous solution (0.1 %, 0.2 mL), dilute 
by 10 mL distilled water, respectively. 
 
Intestinal propulsion assay 
 
ICR mice were randomly divided into control, 
YFKOL (high and low dose) and OLSOL groups 
(n = 10). The treatments of all groups were the 
same as copper sulfate-induced emesis assay. 
All mice were managed with abrosia, but had 
free access to water for 12 h on the third day. 
Carbon powder suspension composed of 10 % 
arabic gum and 5 % active carbon (0.2 mL) was 
administered orally to each mouse after 1 h of 
drugs treatment on the third day. Then mice were 
directly sacrificed for gathering total 
gastrointestinal tract after 20 min of carbon 
powder suspension treatment. The distance 
between pylorus and ileocecum (E), and 
between pylorus and carbon powder forefront (F) 
were determined. Further, the propulsive rate of 
carbon powder, calculated as in Eq 3, was used 
to evaluate the effect of drugs on intestinal 
propulsion. 
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All data are presented as mean ± standard 
deviation (SD, n = 10) and were analyzed by 
one-way ANOVA of Statistical Package and 
Social Sciences (SPSS), version 21.0. P < 0.05 




Effects of YFKOL on cyclophosphamide-
induced leucopenia in mice 
 
The effects of YFKOL and FFEJJ on 
cyclophosphamide-induced leucopenia are 
shown in Figures 1 and 2 separately. After 
treatment with cyclophosphamide, the white 
blood cell count and thighbone marrow 
granulocytes percentage of control group 
significantly (p < 0.05 or 0.01) were inhibited, 
compared with normal group, which indicated the 
modeling was successful. The results shows that 
YFKOL (15 and 30 mL/kg) and FFEJJ (30 mL/kg) 
significantly (p < 0.05 or 0.01) increased the 
white blood cell count and thighbone marrow 
granulocytes percentage, compared with control 
group. 
 
Effect of YFKOL on Co60-induced leucopenia 
in mice 
 
After treatment with Co60, the white blood cell 
count and thighbone marrow granulocytes 
percentage of control group were significantly (p 
< 0.05 or 0.01) inhibited, compared with normal 
group, which indicated the modeling was 
successful. The effects of YFKOL (15 and 30 
mL/kg) and FFEJJ (30 mL/kg) on Co60-induced 
leucopenia indicated that they significantly (p < 
0.05 or 0.01) increased the white blood cell count 
and thighbone marrow granulocytes percentage, 
 
 
Figure 1: Effects of YFKOL and FFEJJ on cyclophosphamide-induced leucopenia model in ICR mice (n = 10); *p 
< 0.05, **p < 0.01, compared with control group 
 
 
Figure 2: Effects of YFKOL and FFEJJ on thighbone marrow granulocytes of cyclophosphamide-induced 
leucopenia model in ICR mice (n = 10); *p < 0.05, **p < 0.01, compared with control group 
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compared with control group, except that YFKOL 
(15 mL/kg) cannot raise thighbone marrow 
granulocytes percentage. The results are 
depicted in Figures 3 and 4. 
 
Effects of YFKOL on copper sulfate-induced 
emesis in pigeons 
 
The results (Table 1) indicate that YFKOL (10 
and 20 mL/kg) and OLSOL (8 mL/kg) 
significantly (p < 0.05 or 0.01) decreased the 
number of emesis induced by copper sulfate 
within 1 h, compared with control group. 
Moreover, YFKOL (20 mL/kg) significantly (p < 
0.05) inhibited incubation period of emesis 





Figure 3: Effects of YFKOL and FFEJJ on Co60-induced leucopenia model in ICR mice (n = 10); *p < 0.05, **p < 
0.01, compared with control group 
 
 
Figure 4: Effects of YFKOL and FFEJJ on thighbone marrow granulocytes of Co60-induced leucopenia model in 
ICR mice (n = 10); *p < 0.05, **p < 0.01, compared with control group 
 
Table 1: Effect of YFKOL on copper sulfate-induced emesis model 
 
Group Dose (mL/kg) Incubation period of emesis (min) Number of emesis (time/h) 
Control  16.4 ± 5.2 54.7 ± 28.9 
OLSOL 8 18.0 ± 6.9 27.4 ± 14.4* 
YFKOL 10 19.5 ± 8.1 30.8 ± 14.7* 
YFKOL 20 26.2 ± 10.5* 22.3 ± 13.0** 
All data stood for mean ± standard deviation (n = 10); *p < 0.05, **p < 0.01 compared with control group 
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Effect of YFKOL on 75 % ethanol-induced 
gastric mucosal lesions in rats 
 
The results (Table 2) indicated that YFKOL (10 
and 20 mL/kg) and OLSOL (8 mL/kg) 
significantly (p < 0.01) decreased ulcer index 
induced by 75 % ethanol, compared with control 
group. Furthermore, the damage inhibition rate 
(%) of OLSOL, 10 mL/kg YFKOL and 20 mL/kg 
YFKOL were 28.7, 36.9 and 57.8 separately. 
 
Effect of YFKOL on gastric emptying and 
intestinal propulsion in mice 
 
The results (Table 3) indicated that YFKOL (10 
and 20 mL/kg) and OLSOL (8 mL/kg) 
significantly (p < 0.05 or 0.01) decreased gastric 
residual rate of methyl orange and improved 





Based on the clinical observation, 
myelosuppression, leucopenia and 
gastrointestinal tract disturbances are the usual 
toxic and side effects of cancer chemotherapy 
and radiotherapy, which do great damage to 
immune system and digestive system of patients 
[15-17]. Thus, reducing these toxic and side 
effects were vital in the treatment of cancer. 
According to the knowledge of traditional 
Chinese medicine, YFKOL was developed to 
reduce chemotherapy- and radiotherapy-induced 
toxic and side effects of myelosuppression, 
leucopenia and gastrointestinal tract 
disturbances. 
 
Cyclophosphamide-based chemotherapy and 
Co60-based radiotherapy are extensively used to 
treat tumor in clinic [18,19]. Thus, 
cyclophosphamide and Co60 were used to 
induce leucopenia in this research [20]. Similarly, 
FFEJJ and OLSOL were selected as positive 
control in this study [21-23]. 
 
The cyclophosphamide-induced and Co60-
induced leucopenia models in mice are two 
common methods used to study the therapeutic 
effects of drugs on leucopenia [24,25]. In this 
work, the two models were used to study the 
immune-enhancement effects of YFKOL. As 
depicted in Figures 1 - 4, chemotherapy- and 
radiotherapy-induced toxic and side effects of 
myelosuppression and leucopenia can be 
significantly decreased by YFKOL through 
increasing white blood cell count and thighbone 
marrow granulocytes percentage. 
 
The copper sulfate-induced emesis model in 
pigeon and ethanol-induced gastric mucosal 
lesions model in rat are commonly used to 
explore the effects of drugs on emesis and 
gastric mucosal lesions [26,27]. In this work, the 
two models were used to study the effects of 
YFKOL on emesis and gastric mucosal lesions. 
As shown in Tables 1 and 2, YFKOL can 
significantly inhibit copper sulfate-induced 
emesis and ethanol-induced gastric mucosal 
lesions by decreasing the number of emesis and 
damage to gastric mucosa. 
 
The gastric emptying and intestinal propulsion 
assays in mice are commonly used to study the 
effects of drugs on gastric emptying and 
intestinal propulsion functions [28]. In this 
research, the two assays were performed to 
study the effects of YFKOL on gastric functions. 
As shown in Table 3, YFKOL can significantly 
improve gastric functions by promoting gastric 
emptying and intestinal propulsion. 
 
Table 2: Effect of YFKOL on 75 % ethanol-induced gastric mucosal lesions model 
 
Group Dose (mL/kg) Ulcer index Damage inhibition rate (%) 
Control  62.8 ± 13.4  
OLSOL 8 44.8 ± 11.8** 28.7 
YFKOL 10 39.6 ± 11.5** 36.9 
YFKOL 20 26.5 ± 9.0** 57.8 
All data stood for mean ± standard deviation (n = 10). **p < 0.01, compared with control group 
 
Table 3: Effect of YFKOL on gastric emptying and intestinal propulsion 
 
Group Dose (mL/kg) Methyl orange residual rate (%) Propulsive rate (%) 
Control  42.0 ± 10.0 68.9 ± 9.8 
OLSOL 8 28.0 ± 8.0** 77.3± 5.8* 
YFKOL 10 25.0 ± 7.0** 81.9 ± 16.2** 
YFKOL 20 24.0 ± 10.0** 82.8 ± 7.2** 
All data stood for mean ± standard deviation (n = 10); *p < 0.05, **p < 0.01, compared with control group 
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YFKOL suppresses symptoms of myelo-
suppression, leucopenia and gastrointestinal 
tract, induced by chemotherapy and 
radiotherapy, by increasing white blood cell count 
and thighbone marrow granulocytes percentage, 
minimizing emesis and damage to gastric 
mucosa, and promoting gastric emptying and 
intestinal propulsion in animal models. This study 
may lead to another approach to tackling the 
toxic and side effects of myelosuppression, 
leucopenia and gastrointestinal tract 
disturbances induced by chemotherapy and 
radiotherapy. Thus, YFKOL may be used to help 
cancer patients to go through the undesirable 
effects of chemotherapy and radiotherapy, and 
therefore further efforst are required to 
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